Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nisseiken is a Japanese animal-health company focused on the research, manufacture, and wholesale of veterinary medicinal products, particularly vaccines and diagnostic agents. The company markets veterinary biologics across poultry, pig, horse, cattle, dog and cat, and fish categories, indicating a broad commercial portfolio in preventive animal health. Its corporate messaging emphasizes infectious-disease prevention, livestock productivity, food safety, and the One Health connection between animal and human health. Nisseiken operates from Ome, Tokyo, with a major facility in Kobuchisawa, Yamanashi, and has roots linked to the Nippon Institute for Biological Science. For a biotech analyst, Nisseiken is best understood as a long-established commercial veterinary vaccine manufacturer rather than a human therapeutics biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nisseiken.